Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study

<div>Course of clinical symptoms at visit 2 and visit 3 among patients with symptoms at baseline. Patients with (a) fever, (b) cough, (c) dyspnoea, (d) sputum volume, (e) sputum purulence, (f) chest discomfort, (g) fatigue, and (h) sleep disturbance at baseline whose symptoms were relieved (i.e., switched to absent), improved (decreased intensity), unchanged, or worsened (increased severity) at visit 2 and visit 3.</div>

Canadian Respiratory Journal

fig3

Figure 3

Figure 3: Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study 

Figure 3 | Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study 